AMGN Amgen Inc.
Healthcare$338.18+0.00%OpenMarket Cap: $182.52B
As of 2026-05-26
Institutional Ownership Summary
Investors Holding
3,142
13F Shares
436,015,921
Ownership %
81.0%
New Positions
400
Increased Positions
1583
Closed Positions
158
Reduced Positions
1093
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| VanEck Biotech ETF | 153,582 | 15.05% | |
| Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 1,248,174 | 14.12% | |
| Pacer Salt High truBeta US Market ETF | 1,248,174 | 14.12% | |
| 1,248,174 | 14.12% | ||
| 1,248,174 | 14.12% | ||
| Pacer Salt Low truBeta US Market ETF | 1,248,174 | 14.12% | |
| Invesco Nasdaq Biotechnology ETF | 15,591 | 7.78% | |
| iShares Biotechnology ETF | 1,733,148 | 7.77% | |
| ProShares - Ultra Nasdaq Biotechnology | 11,860 | 5.66% | |
| Pacer CSOP FTSE China A50 ETF | 88,647 | 5.17% | |
| Invesco Pharmaceuticals ETF | 55,671 | 5.02% | |
| Invesco Biotechnology & Genome ETF | 33,651 | 4.91% | |
| Global X - Dow 30 Covered Call ETF | 21,431 | 4.83% | |
| State Street SPDR Dow Jones Industrial Average ETF Trust | 5,547,661 | 4.75% | |
| Invesco Dow Jones Industrial Average Dividend ETF | 57,409 | 4.54% | |
| Portfolio Building Block World Pharma and Biotech Index ETF | 87,967 | 4.43% | |
| Monarch Blue Chips Core Index ETF | 17,055 | 4.10% | |
| Amplify CWP Enhanced Dividend Income ETF | 719,839 | 3.87% | |
| Schwab U.S. Dividend Equity ETF | 9,167,321 | 3.84% | |
| ProShares - Ultra Dow30 | 44,771 | 3.78% |